Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain

The development of clinical practice recommendations or guidelines for the clinical use of biomarkers is an issue of great importance with regard to adverse drug reactions. The potential of pharmacogenomic biomarkers has been extensively investigated in recent years. However, several barriers to imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Agúndez, José A. G., Abad-Santos, Francisco, Aldea, Ana, Alonso-Navarro, Hortensia, Bernal, María L., Borobia, Alberto M., Borrás, Emma, Carballo, Miguel, Carvajal, Alfonso, García-Muñiz, José D., Gervasini, Guillermo, Jiménez-Jiménez, Félix J., Lucena, María I., Martínez, Carmen, Sacristán, José A., Salado, Inés, Sinués, Blanca, Vicente, Jorge, García-Martín, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516180/
https://www.ncbi.nlm.nih.gov/pubmed/23233861
http://dx.doi.org/10.3389/fgene.2012.00273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516180/
https://www.ncbi.nlm.nih.gov/pubmed/23233861
http://dx.doi.org/10.3389/fgene.2012.00273

Ejemplares similares